Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer

Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.Read More